{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:32:52Z","timestamp":1790371972798,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12716-6","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:02:20Z","timestamp":1722528140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Ma\u0142gorzata","family":"Fr\u0105k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ku\u017anar-Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Pazdrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"K\u0119dra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Chmielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Milanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"12716_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"S Chen","year":"2013","unstructured":"Chen S, Mellan I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1\u201310.","journal-title":"Immunity"},{"key":"12716_CR2","doi-asserted-by":"publisher","first-page":"1129195","DOI":"10.3389\/fonc.2023.1129195","volume":"13","author":"K Rangamuwa","year":"2023","unstructured":"Rangamuwa K, et al. Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review. Front Oncol. 2023;13:1129195. https:\/\/doi.org\/10.3389\/fonc.2023.1129195.","journal-title":"Front Oncol"},{"key":"12716_CR3","doi-asserted-by":"publisher","first-page":"799455","DOI":"10.3389\/fimmu.2021.799455","volume":"12","author":"C Genova","year":"2021","unstructured":"Genova C, et al. Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade. Front Immunol. 2021;12:799455. https:\/\/doi.org\/10.3389\/fimmu.2021.799455.","journal-title":"Front Immunol"},{"key":"12716_CR4","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.3390\/ijms21165845","volume":"21","author":"A Bleve","year":"2020","unstructured":"Bleve A, Durante B, Sica A, Consonni FM. Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad. Int J Mol Sci. 2020;21:5845. https:\/\/doi.org\/10.3390\/ijms21165845.","journal-title":"Int J Mol Sci"},{"key":"12716_CR5","unstructured":"Cancer Today. Globocan 2022 (version 1.1) \u2013\u200908.02.2024. https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=cancer&group_populations=1&sexes=0&types=0."},{"key":"12716_CR6","doi-asserted-by":"publisher","first-page":"1213297","DOI":"10.3389\/fonc.2023.1213297","volume":"13","author":"F Wang","year":"2023","unstructured":"Wang F, Xia T, Li Z, Gao X, Fang X. Current status of clinical trial research and application of immune checkpoint inhibitors for non-small cell lung cancer. Front Oncol. 2023;13:1213297. https:\/\/doi.org\/10.3389\/fonc.2023.1213297.","journal-title":"Front Oncol"},{"key":"12716_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(23)00774-2","volume":"402","author":"SM Lee","year":"2023","unstructured":"Lee SM, et al. First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. Lancet. 2023;402:451\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(23)00774-2.","journal-title":"Lancet"},{"key":"12716_CR8","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/cncr.34348","volume":"128","author":"A Cortellini","year":"2022","unstructured":"Cortellini A, et al. Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: a post hoc analysis of the phase 3 OAK trial. Cancer. 2022;128:3067\u201379. https:\/\/doi.org\/10.1002\/cncr.34348.","journal-title":"Cancer"},{"key":"12716_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cllc.2022.12.003","volume":"24","author":"M Chen","year":"2023","unstructured":"Chen M, et al. Comparison of chemotherapy plus pembrolizumab vs. chemotherapy alone in EGFR-mutant non-small-cell lung cancer patients. Clin Lung Cancer. 2023;24:278\u201386. https:\/\/doi.org\/10.1016\/j.cllc.2022.12.003.","journal-title":"Clin Lung Cancer"},{"key":"12716_CR10","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/life12060880","volume":"12","author":"K Rounis","year":"2022","unstructured":"Rounis K, et al. Cancer cachexia and antitumor immunity: common mediators and potential targets for new therapies. Life (Basel). 2022;12:880. https:\/\/doi.org\/10.3390\/life12060880.","journal-title":"Life (Basel)"},{"key":"12716_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.it.2021.11.004","volume":"43","author":"I Potapov","year":"2022","unstructured":"Potapov I, Kanneganti TD, del Sol A. Fostering experimental and computational synergy to modulate hyperinflammation. Trends Immunol. 2022;43:78\u201392. https:\/\/doi.org\/10.1016\/j.it.2021.11.004.","journal-title":"Trends Immunol"},{"key":"12716_CR12","doi-asserted-by":"publisher","first-page":"646362","DOI":"10.3389\/fgene.2021.646362","volume":"12","author":"T Cheng","year":"2021","unstructured":"Cheng T, Zhang J, Liu D, Lai G, Wen X. Prognosis of non-small-cell lung cancer patients with lipid metabolism pathway alternations to immunotherapy. Front Genet. 2021;12:646362. https:\/\/doi.org\/10.3389\/fgene.2021.646362.","journal-title":"Front Genet"},{"key":"12716_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019;25:141\u201351. https:\/\/doi.org\/10.1038\/s41591-018-0221-5.","journal-title":"Nat Med"},{"key":"12716_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","volume":"42","author":"S Pereira","year":"2021","unstructured":"Pereira S, Cline DL, Glavas MM, Covey SD, Kieffer TJ. Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev. 2021;42:1\u201328. https:\/\/doi.org\/10.1210\/endrev\/bnaa027.","journal-title":"Endocr Rev"},{"key":"12716_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines12010097","volume":"12","author":"JW Kim","year":"2024","unstructured":"Kim JW, Kim JH, Lee YJ. The role of adipokines in tumor progression and its association with obesity. Biomedicines. 2024;12:97. https:\/\/doi.org\/10.3390\/biomedicines12010097.","journal-title":"Biomedicines"},{"key":"12716_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbadis.2013.05.009","volume":"1842","author":"RB Harris","year":"2014","unstructured":"Harris RB. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta. 2014;1842:414\u201323. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.009.","journal-title":"Biochim Biophys Acta"},{"key":"12716_CR17","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s00262-023-03533-0","volume":"72","author":"E Vita","year":"2023","unstructured":"Vita E, et al. Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC). Cancer Immunol Immunother. 2023;72:3803\u201312. https:\/\/doi.org\/10.1007\/s00262-023-03533-0.","journal-title":"Cancer Immunol Immunother"},{"key":"12716_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/endrev\/bnab025","volume":"43","author":"A Jais","year":"2022","unstructured":"Jais A, Br\u00fcning JC. Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus. Endocr Rev. 2022;43:314\u201328. https:\/\/doi.org\/10.1210\/endrev\/bnab025.","journal-title":"Endocr Rev"},{"key":"12716_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","volume":"13","author":"V Abella","year":"2017","unstructured":"Abella V, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13:100\u20139. https:\/\/doi.org\/10.1038\/nrrheum.2016.209.","journal-title":"Nat Rev Rheumatol"},{"key":"12716_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s12013-014-0047-9","volume":"70","author":"Z Jia","year":"2014","unstructured":"Jia Z, Liu Y, Cui S. Adiponectin induces breast cancer cell migration and growth factor expression. Cell Biochem Biophys. 2014;70:1239\u201345. https:\/\/doi.org\/10.1007\/s12013-014-0047-9.","journal-title":"Cell Biochem Biophys"},{"key":"12716_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cytogfr.2017.11.002","volume":"38","author":"A Ray","year":"2017","unstructured":"Ray A, Cleary MP. The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev. 2017;38:80\u201397. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.11.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"12716_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","volume":"15","author":"N Kloting","year":"2014","unstructured":"Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277\u201387. https:\/\/doi.org\/10.1007\/s11154-014-9301-0.","journal-title":"Rev Endocr Metab Disord"},{"key":"12716_CR23","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.1152\/ajpendo.00057.2011","volume":"302","author":"CD Wrann","year":"2012","unstructured":"Wrann CD, et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab. 2012;302:E108\u201316. https:\/\/doi.org\/10.1152\/ajpendo.00057.2011.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"12716_CR24","doi-asserted-by":"publisher","unstructured":"Tsiotra PC, Boutati E, Dimitriadis G, Raptis SA. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res. Int 2013, 487081 (2013). https:\/\/doi.org\/10.1155\/2013\/487081","DOI":"10.1155\/2013\/487081"},{"key":"12716_CR25","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.3390\/ijms21165887","volume":"21","author":"A P\u00e9rez-P\u00e9rez","year":"2020","unstructured":"P\u00e9rez-P\u00e9rez A, S\u00e1nchez-Jim\u00e9nez F, Vilari\u00f1o-Garc\u00eda T, S\u00e1nchez-Margalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020;21:5887. https:\/\/doi.org\/10.3390\/ijms21165887.","journal-title":"Int J Mol Sci"},{"key":"12716_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/nu15030715","volume":"15","author":"S Afrin","year":"2023","unstructured":"Afrin S, Ramaiyer M, Begum UAM, Borahay MA. Adipocyte and adipokines promote a uterine leiomyoma friendly microenvironment. Nutrients. 2023;15:715. https:\/\/doi.org\/10.3390\/nu15030715.","journal-title":"Nutrients"},{"key":"12716_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jcp.20472","volume":"207","author":"C Garofalo","year":"2006","unstructured":"Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol. 2006;207:12\u201322. https:\/\/doi.org\/10.1002\/jcp.20472.","journal-title":"J Cell Physiol"},{"key":"12716_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12944-022-01766-z","volume":"21","author":"Y Zou","year":"2022","unstructured":"Zou Y, Yu X, Zhou C, Zhu C, Yuan Y. Adverse effects of low serum lipoprotein cholesterol on the immune microenvironment in gastric cancer: a case-control study. Lipids Health Dis. 2022;21:150. https:\/\/doi.org\/10.1186\/s12944-022-01766-z.","journal-title":"Lipids Health Dis"},{"key":"12716_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-020-0457-0","volume":"17","author":"L Munoz-Erazo","year":"2020","unstructured":"Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol. 2020;17:570\u20135. https:\/\/doi.org\/10.1038\/s41423-020-0457-0.","journal-title":"Cell Mol Immunol"},{"key":"12716_CR30","doi-asserted-by":"publisher","first-page":"692859","DOI":"10.3389\/fimmu.2021.692859","volume":"12","author":"N Cheng","year":"2021","unstructured":"Cheng N, et al. Prognostic value of tumor-infiltrating lymphocytes and tertiary lymphoid structures in Epstein-Barr virus-associated and -negative gastric carcinoma. Front Immunol. 2021;12:692859. https:\/\/doi.org\/10.3389\/fimmu.2021.692859.","journal-title":"Front Immunol"},{"key":"12716_CR31","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3892\/ol.2020.11828","volume":"20","author":"Q Li","year":"2020","unstructured":"Li Q, et al. CD8(+) T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer. Oncol Lett. 2020;20:2655\u201364. https:\/\/doi.org\/10.3892\/ol.2020.11828.","journal-title":"Oncol Lett"},{"key":"12716_CR32","doi-asserted-by":"publisher","first-page":"eaaz6667","DOI":"10.1126\/scitranslmed.aaz6667","volume":"12","author":"M Hao","year":"2020","unstructured":"Hao M, et al. Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Sci Transl Med. 2020;12:eaaz6667. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6667.","journal-title":"Sci Transl Med"},{"key":"12716_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10226","volume":"475","author":"C Liu","year":"2011","unstructured":"Liu C, et al. Oxysterols direct B-cell migration through EBI2. Nature. 2011;475:519\u201323. https:\/\/doi.org\/10.1038\/nature10226.","journal-title":"Nature"},{"key":"12716_CR34","doi-asserted-by":"publisher","first-page":"102241","DOI":"10.1016\/j.esmoop.2024.102241","volume":"9","author":"H Wen","year":"2024","unstructured":"Wen H, et al. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies. ESMO Open. 2024;9:102241. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102241.","journal-title":"ESMO Open"},{"key":"12716_CR35","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1055\/a-1868-9164","volume":"147","author":"H Scher\u00fcbl","year":"2022","unstructured":"Scher\u00fcbl H. Metabolic syndrome and cancer risk. Dtsch Med Wochenschr. 2022;147:1068\u201377. https:\/\/doi.org\/10.1055\/a-1868-9164.","journal-title":"Dtsch Med Wochenschr"},{"key":"12716_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-024-01308-w","volume":"16","author":"J Liu","year":"2024","unstructured":"Liu J, Wang R, Tan S, Zhao X, Hou A. Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis. Diabetol Metab Syndr. 2024;16:63. https:\/\/doi.org\/10.1186\/s13098-024-01308-w.","journal-title":"Diabetol Metab Syndr"},{"key":"12716_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000496625","volume":"12","author":"S Jasinski-Bergner","year":"2019","unstructured":"Jasinski-Bergner S, Kielstein H. Adipokines regulate the expression of tumor-relevant microRNAs. Obes Facts. 2019;12:211\u201325. https:\/\/doi.org\/10.1159\/000496625.","journal-title":"Obes Facts"},{"key":"12716_CR38","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","volume":"25","author":"W Tomaszewski","year":"2019","unstructured":"Tomaszewski W, Sanchez-Perez L, Gajewski TF. Brain tumor microenvironment and host state: implications for immunotherapy. Clin Cancer Res. 2019;25:4202\u201310. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1627.","journal-title":"Clin Cancer Res"},{"key":"12716_CR39","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.2019.0463","volume":"321","author":"WJ Murphy","year":"2019","unstructured":"Murphy WJ, Longo DL. The surprisingly positive association between obesity and cancer immunotherapy efficacy. JAMA. 2019;321:1247\u20138. https:\/\/doi.org\/10.1001\/jama.2019.0463.","journal-title":"JAMA"},{"key":"12716_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse G, et al. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer. JAMA Oncol. 2020;6:512\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2019.5241.","journal-title":"JAMA Oncol"},{"key":"12716_CR41","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/jcsm.13367","volume":"14","author":"JH Lee","year":"2023","unstructured":"Lee JH, et al. Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy. J Cachexia Sarcopenia Muscle. 2023;14:2898\u2013907. https:\/\/doi.org\/10.1002\/jcsm.13367.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"12716_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/mco.2023.2703","volume":"20","author":"H Guo","year":"2024","unstructured":"Guo H, et al. Prognostic value of obesity in patients with cancer treated with immune checkpoint inhibitors: an updated meta-analysis and systematic review. Mol Clin Oncol. 2024;20:5. https:\/\/doi.org\/10.3892\/mco.2023.2703.","journal-title":"Mol Clin Oncol"},{"key":"12716_CR43","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.3390\/cancers15194684","volume":"15","author":"D Rocco","year":"2023","unstructured":"Rocco D, et al. Prognostic factors in advanced non-small cell lung cancer patients treated with immunotherapy. Cancers. 2023;15:4684. https:\/\/doi.org\/10.3390\/cancers15194684.","journal-title":"Cancers"},{"key":"12716_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fonc.2019.00596","volume":"9","author":"F S\u00e1nchez-Jim\u00e9nez","year":"2019","unstructured":"S\u00e1nchez-Jim\u00e9nez F, P\u00e9rez-P\u00e9rez A, de la Cruz-Merino L, S\u00e1nchez-Margalet V. Obesity and breast cancer: role of leptin. Front Oncol. 2019;9:596. https:\/\/doi.org\/10.3389\/fonc.2019.00596.","journal-title":"Front Oncol"},{"key":"12716_CR45","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.3390\/cells12212551","volume":"12","author":"AW Hahn","year":"2023","unstructured":"Hahn AW, Venkatesh N, Msaoeul P, McQuade JL. The influence of obesity on outcomes with immune checkpoint blockade: clinical evidence and potential biological mechanisms. Cells. 2023;12:2551. https:\/\/doi.org\/10.3390\/cells12212551.","journal-title":"Cells"},{"key":"12716_CR46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1186\/s12885-023-11512-y","volume":"23","author":"T Zhang","year":"2023","unstructured":"Zhang T, Li S, Chang J, Qin Y, Ii C. Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. BMC Cancer. 2023;23:1023. https:\/\/doi.org\/10.1186\/s12885-023-11512-y.","journal-title":"BMC Cancer"},{"key":"12716_CR47","doi-asserted-by":"publisher","first-page":"e21209","DOI":"10.1200\/JCO.2021.39.15_suppl.e21209","volume":"39","author":"JP Palmer","year":"2021","unstructured":"Palmer JP, et al. Overweight or obese patients may take longer to respond and be less responsive to immune checkpoint inhibitors in non-small cell lung cancer: a retrospective review. J Clin Oncol. 2021;39:e21209. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.e21209.","journal-title":"J Clin Oncol"},{"key":"12716_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejca.2022.10.013","volume":"178","author":"S Antoun","year":"2023","unstructured":"Antoun S, et al. Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle. Eur J Cancer. 2023;178:49\u201359. https:\/\/doi.org\/10.1016\/j.ejca.2022.10.013.","journal-title":"Eur J Cancer"},{"key":"12716_CR49","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.4049\/jimmunol.2001152","volume":"207","author":"SO Dudzinski","year":"2021","unstructured":"Dudzinski SO, et al. Leptin augments antitumor immunity in obesity by repolarizing tumor-associated macrophages. J Immunol. 2021;207:3122\u201330. https:\/\/doi.org\/10.4049\/jimmunol.2001152.","journal-title":"J Immunol"},{"key":"12716_CR50","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.ijrobp.2023.06.670","volume":"117","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. The baseline serum lipid levels and outcomes of NSCLC patients receiving immunotherapy combined of non-combined with radiotherapy: a single center retrospective study. Int J Radiat Oncol. 2023;117:e11.","journal-title":"Int J Radiat Oncol"},{"key":"12716_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12944-023-01960-7","volume":"23","author":"L Liu","year":"2024","unstructured":"Liu L, et al. Lipid alterations play a role in the integration of PD-1\/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer. Lipids Health Dis. 2024;23:16. https:\/\/doi.org\/10.1186\/s12944-023-01960-7.","journal-title":"Lipids Health Dis"},{"key":"12716_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/ijc.24372","volume":"125","author":"M Terrasi","year":"2009","unstructured":"Terrasi M, et al. Functional analysis of the \u2013\u20092548G\/A leptin gene polymorphism in breast cancer cells. Int J Cancer. 2009;125:1038\u201344. https:\/\/doi.org\/10.1002\/ijc.24372.","journal-title":"Int J Cancer"},{"key":"12716_CR53","doi-asserted-by":"publisher","unstructured":"Marcello MA et al. Polymorphism in LEP and LEPR may modify leptin levels and represent risk factors for thyroid cancer. Int. J. Endocrinol 2015, 73218 (2015). https:\/\/doi.org\/10.1155\/2015\/173218","DOI":"10.1155\/2015\/173218"},{"key":"12716_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/DMSO.S391869","volume":"16","author":"AA Mohamed","year":"2023","unstructured":"Mohamed AA, et al. The impact of LEP rs7799039 polymorphism and obesity on the severity of coronavirus disease-19. Diabetes Metab Syndr Obes. 2023;16:515\u201322. https:\/\/doi.org\/10.2147\/DMSO.S391869.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"12716_CR55","doi-asserted-by":"publisher","first-page":"102222","DOI":"10.1016\/j.jksus.2022.102222","volume":"34","author":"SS Shetty","year":"2022","unstructured":"Shetty SS, Kumari N, Hegde P, Roopashree PG, Suhasini PC. Leptin gene polymorphism rs7799039; G2548A, metabolic and oxidative stress markers in polycystic ovarian syndrome. J King Saud Univ Sci. 2022;34:102222. https:\/\/doi.org\/10.1016\/j.jksus.2022.102222.","journal-title":"J King Saud Univ Sci"},{"key":"12716_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbcan.2012.01.002","volume":"1825","author":"S Guo","year":"2012","unstructured":"Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta Rev Cancer. 2012;1825:207\u201322. https:\/\/doi.org\/10.1016\/j.bbcan.2012.01.002.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"12716_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2007.10.799","volume":"198","author":"SM Kim","year":"2008","unstructured":"Kim SM, et al. Association of leptin receptor polymorphisms Lys109Arg and Gln223Arg with serum leptin profile and bone mineral density in Korean women. Am J Obstet Gynecol. 2008;198:1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2007.10.799.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:14:04Z","timestamp":1722528844000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12716"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12716-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave their written consent to participate in the study. The study was approved by the local Bioethics Committee at the Medical University of Lublin (approval number \u2013 KE-0254\/95\/2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have declared that no conflict of interest exists.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"937"}}